MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
about
Computational Approaches for the Discovery of Human Proteasome Inhibitors: An OverviewLipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cellsThe ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infectionRole of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein.EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanismSilibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent MannerCell fate determination in cisplatin resistance and chemosensitizationPost-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells.Pannexin3 inhibits TNF-α-induced inflammatory response by suppressing NF-κB signalling pathway in human dental pulp cells.Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?Recent advances in defining the ubiquitylome.Chemical biology approach for the development of hypoxia inducible factor (HIF) inhibitor LW6 as a potential anticancer agent.MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.Lamotrigine Attenuates Proteasome Inhibition-Induced Apoptosis by Suppressing the Activation of the Mitochondrial Pathway and the Caspase-8- and Bid-Dependent Pathways.Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni.Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells.Calreticulin and Arginylated Calreticulin Have Different Susceptibilities to Proteasomal Degradation.Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132.Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.Enhanced p62 Is Responsible for Mitochondrial Pathway-Dependent Apoptosis and Interleukin-1β Production at the Early Phase by Monosodium Urate Crystals in Murine Macrophage.3,4,5-tricaffeoylquinic acid attenuates proteasome inhibition-mediated programmed cell death in differentiated PC12 cells.BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death.ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination.Caspase-mediated cleavage of the centrosomal proteins during apoptosis.
P2860
Q26738752-06BF4DFD-4E1E-4680-8311-D79A4785F7E7Q28538284-CFE4343E-52C9-4DE4-A1E1-20DEFA2FD334Q28546865-1EC342E0-826E-4F2C-9ABE-E2B6F3E6B6F8Q34393817-34A32CFD-50F5-4477-9085-55E8F3D0F4AFQ35080559-43FDC621-859C-4E98-AE20-56A14A862DDBQ35882968-6781BB63-72B7-422B-BD85-002FE967D1D6Q36168253-4D9666D1-12FE-4EB6-9895-E45AD96028ABQ36234820-59D92525-4F77-474D-97BC-7865229B9541Q37269025-E5C05F21-6804-4111-8684-49D2B68044BBQ37392887-9FC4DE9C-CB75-48AD-B461-2A8941DF8308Q37662870-2747FFCF-D90C-4675-A12C-4FF353AE7470Q38190096-2AC08CC5-A58E-4216-B15A-51CAC1CEF036Q38222939-E356ADA8-55EB-40F5-87BC-37E8C768A329Q38574434-F8835C5A-0603-4047-B8B9-1637AFD9AEB5Q38720677-A5EBC485-EE0D-470A-99C1-945146318143Q38755091-BD881355-14A6-41FA-A95B-26630F8C9729Q38768222-142973DA-6510-4F58-87D8-75F525E9C3E4Q39084493-83121A0C-03BB-4440-9081-7B563BF2CD07Q40045616-3547B43E-7F6A-4AAF-9CDE-B177AFE55350Q41982178-069134C3-4948-4840-98DA-842CBA28B75FQ42126098-DE5A91A3-B53F-4FDA-BF60-93BF97CA7F2FQ42182675-26C8B78D-3A22-443C-B7F9-BDC873876093Q45786963-DD43ED6B-205E-4772-B9BF-6DDAE749170EQ46536374-5095D9BD-705F-405D-BA4B-5A5DA99613D3Q46894541-69AA17D4-615E-4661-A74D-CD2B9F2F492CQ47240693-FD5306CF-D6DB-4C90-A794-F0E40209179EQ55093835-5F7E784F-5D92-47EE-B6C8-BC9B9F2FC27EQ55112478-12D30BDC-533A-484F-A89E-05C62D3FADC7
P2860
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
@en
type
label
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
@en
prefLabel
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
@en
P2860
P1476
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
@en
P2093
P2860
P356
10.1111/J.1743-7563.2012.01535.X
P577
2012-05-15T00:00:00Z